rs144711161
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_001206927.2(DNAH8):c.9194+1G>A variant causes a splice donor change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000116 in 1,568,144 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_001206927.2 splice_donor
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH8 | NM_001206927.2 | c.9194+1G>A | splice_donor_variant | ENST00000327475.11 | NP_001193856.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH8 | ENST00000327475.11 | c.9194+1G>A | splice_donor_variant | 5 | NM_001206927.2 | ENSP00000333363 | P2 | |||
DNAH8 | ENST00000359357.7 | c.8543+1G>A | splice_donor_variant | 2 | ENSP00000352312 | A2 | ||||
DNAH8 | ENST00000449981.6 | c.9194+1G>A | splice_donor_variant | 5 | ENSP00000415331 |
Frequencies
GnomAD3 genomes AF: 0.000132 AC: 20AN: 152006Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000838 AC: 18AN: 214762Hom.: 0 AF XY: 0.0000772 AC XY: 9AN XY: 116518
GnomAD4 exome AF: 0.000114 AC: 162AN: 1416020Hom.: 0 Cov.: 29 AF XY: 0.000125 AC XY: 88AN XY: 701504
GnomAD4 genome AF: 0.000131 AC: 20AN: 152124Hom.: 0 Cov.: 33 AF XY: 0.000121 AC XY: 9AN XY: 74360
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 07, 2023 | This sequence change affects a donor splice site in intron 62 of the DNAH8 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in DNAH8 are known to be pathogenic (PMID: 24307375, 32619401, 32681648). This variant is present in population databases (rs144711161, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with DNAH8-related conditions. ClinVar contains an entry for this variant (Variation ID: 238657). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
DNAH8-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 16, 2024 | The DNAH8 c.9194+1G>A variant is predicted to disrupt the GT donor site and interfere with normal splicing. To our knowledge, this variant has not been reported in literature. This variant is reported in 0.015% of alleles in individuals of European (Non-Finnish) descent in gnomAD. However, loss-of-function variants have been reported to be causative for DNAH8-related disorders (for example, Watson et al. 2014. PubMed ID: 24307375; Liu et al. 2020. PubMed ID: 32619401; Yang et al. 2020. PubMed ID: 32681648; Zhou et al. 2021. PubMed ID: 33611675). In ClinVar, the c.9194+1G>A variant is interpreted as likely pathogenic (ClinVar ID: 239924). Based on these observations, this variant is classified as likely pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at